University of California San Francisco
Give to UCSFUCSF is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease – and bring them quickly to patients.
Bay Area photographer Barbara Ries shares her thoughts on one of her award-winning images of the Navajo Nation.
Norway strives to rehabilitate instead of punish. UCSF’s Amend program is showing that this model can help solve the public health crisis plaguing the American correctional system.
UCSF alum and Moderna president Stephen Hoge, MD '03, shares what it was like to design a desperately needed vaccine in record time.
This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You
In 1981, a mysterious illness began overwhelming the San Francisco community. Since those early days of the epidemic, UCSF has steadfastly been at the forefront of patient care, research and community partnerships in the battle against HIV and AIDS.
Researchers from the UCSF School of Nursing have joined a newly launched national collaborative to study the impacts of COVID-19 on members of the lesbian, gay, bisexual, transgender and queer communities.
UCSF experts will showcase how taking a precision medicine approach helped to combat the COVID-19 pandemic during the Precision Medicine World Conference on June 14-18.
Six health care experts grapple with how to address race without being racist.
Kim Rhoads, MD, MPH, founded Umoja Health Partners to unite about 30 community organizations combating COVID-19 in the Bay Area’s Black communities. She shares why the Umoja approach is working.
The study is the first comprehensive review of fatalities linked to the deadly chemical in the United States and identified more deaths than previously reported.
In the third installment of UCSF’s three-part series, “COVID-19: The Path Forward,” a panel of health and policy experts met March 23 to examine COVID-19's impact on our society and look ahead to how we rebuild and prepare for future pandemics.
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells.
UC San Francisco and Johns Hopkins University today announced the launch of the Opioid Industry Documents Archive, a digital repository of publicly disclosed documents from recent judgments, settlements, and ongoing lawsuits concerning the opioid crisis.
A panel of health experts and government officials addressed the myriad issues related to COVID-19, including health disparities before and during the pandemic, public partnerships, and how communities can better address inequities to prevent the next crisis.
In the week after former President Donald J. Trump tweeted about “the Chinese virus,” the number of coronavirus-related tweets with anti-Asian hashtags rose precipitously, a new study from UCSF has found.
Further studies may reveal different patterns, including the possibility that evidence of abuse may not be apparent for months to follow, or failure by clinicians to identify abuse.
Friends, family members and former colleagues, including former President Bill Clinton celebrated the life of former UC San Francisco Chancellor Phillip R. Lee in a virtual event.
As UCSF honored Black History Month, we asked some of our faculty, staff, and students to share their experiences, their inspirations, and where they find hope for the future.
New results from an ongoing collaborative effort to slow the spread of COVID-19 shows that the prevalence of a coronavirus lineage, characterized by the L452R substitution and two other mutations in the virus’s spike protein, has significantly increased in recent months.
The camp was co-founded by Arthur Ablin, MD, the former chief of pediatric oncology at UCSF.
As its supply of COVID-19 vaccines increases, UC San Francisco is expanding its vaccination efforts to those most at risk – the elderly and health care workers in the community